Campaign for Esophageal Cancer Research Funding
Over the past two years, more than $11 million in new federal funding has been awarded to Esophageal Cancer researchers [...]
April is Esophageal Cancer Awareness Month
ECAN launched the campaign for April to be recognized as Esophageal Cancer Awareness Month in 2009. Since then, more than [...]
Preventing Chemo Brain? Study Identifies Potential Approach for Common Problem
A side effect of some cancer treatments commonly referred to as “chemo brain” has received increasing attention from researchers lately. [...]
Groundbreaking Study on How Barrett’s Esophagus becomes Cancer
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus in the fight to stop [...]
She Dealt with the Anguish of Losing Her Dad to Esophageal Cancer …
And went on to win the Silver Medal in the Tokyo Olympics in the Women's 1500 Meter competition! Erica Sullivan [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 Inhibitors for patients with Esophageal [...]
A Reason for Optimism
This is the 13th anniversary of my husband's death. It may sound like a contradiction, but it is a reason [...]
ECAN Experts cited in US News & World Report
"Esophageal Cancer: What to Know" is a new report from U.S. News & World Report by contributing writer David Levine. [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for [...]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new therapy for adult patients with locally advanced or metastatic HER2+ [...]